By:
Ken Klukowski
06/27/11 10:13 PM
Trial lawyers cannot sue drug manufacturers for defective warning labels on generics if labels were approved by the U.S. Food and Drug Administration, according to the U.S. Supreme Court. The 5-4 Pliva v. Mensing decision announced last week was a defeat for class-action trial lawyers hoping to profit on litigation based on allegations
Pliva grew out of the fact that the medicine Reglan can cause certain neurological side effects.
Read More